Keyphrases
Indonesia
100%
Curcumin
82%
Indonesian
55%
Oxidative Stress
47%
Leaf Extract
37%
Phaleria Macrocarpa
36%
Sprague-Dawley Rats
34%
Rat Model
33%
Doxorubicin
33%
Jakarta
32%
Dextran Sulfate Sodium
31%
Cisplatin
31%
Mangiferin
28%
MRNA Expression
28%
Nanocurcumin
28%
Pada
26%
Mahkota Dewa
26%
α-mangostin
23%
Apoptosis
22%
Clinical Trials
22%
Randomized Controlled Trial
21%
Inflammation
21%
Ethanol Extract
21%
Diabetic Foot Ulcer
20%
Antioxidant System
19%
Endoplasmic Reticulum Stress (ER stress)
19%
Daunorubicin
19%
Hyaluronic Acid
19%
Drug Transporters
18%
Protective Effect
18%
Kidney
18%
Antioxidant
18%
Protein Expression
18%
Platelet-rich Fibrin
18%
Liver
18%
Placebo
18%
Iron Overload
17%
Primaquine
17%
Streptozotocin-induced Diabetic Rats
17%
COVID-19
17%
Moringa Oleifera
16%
Insulin Resistance
16%
Leukemia Patients
16%
Tumor Necrosis Factor-α
16%
Streptozotocin-induced
16%
Streptozotocin
16%
Tuberculosis Patients
16%
Cardiotoxicity
16%
Plasma Concentration
15%
Type 1 Diabetes Mellitus (T1DM)
15%
Type 2 Diabetes Mellitus (T2DM)
15%
Oxidative Stress Markers
15%
Risk Factors
15%
Beneficial Effects
15%
Metabolic Syndrome
14%
Negative Control
14%
Anti-inflammatory Effect
14%
Interleukin-6
14%
Confidence Interval
14%
Nephrotoxicity
14%
Diabetes
14%
Diabetic Nephropathy
13%
In Vitro Study
13%
Caspase-3
13%
MCF-7
13%
Breast Cancer Cells
13%
Angiotensin II (Ang II)
13%
Rifampicin
13%
Meta-analysis
13%
High-fat Diet
13%
Hepatic Stellate Cells
13%
Randomized Placebo-controlled Trial
12%
Healthy Volunteers
12%
Prostate
12%
Triple-negative Breast Cancer Cells
12%
Treatment Group
12%
Cardioprotection
12%
Diabetic
12%
Tuberculosis Treatment
12%
Mouse Colon
12%
Pulmonary Tuberculosis
12%
Cell Viability
11%
Blood Samples
11%
Dari
11%
Chitosan Nanoparticles
11%
Transmembrane
11%
Androgens
11%
Pre-diabetes (pre-DM)
11%
Lunasin
11%
Cytochrome P450 2D6 (CYP2D6)
11%
Silver Nanoparticles
11%
Olmesartan
11%
Quercetin
11%
Experimental Autoimmune Myocarditis
11%
Diabetic Cardiomyopathy
11%
Chronic Myeloid Leukemia
11%
No Significant Difference
11%
Clopidogrel Resistance
11%
Aging
11%
Malondialdehyde
11%
Pharmacology, Toxicology and Pharmaceutical Science
Curcumin
85%
Antioxidant
47%
Diabetes Mellitus
42%
Breast Cancer
39%
Streptozotocin
38%
Messenger RNA
38%
Inflammation
38%
Dextran Sulfate
37%
Cisplatin
37%
Doxorubicin
36%
Sprague Dawley Rat
36%
Randomized Controlled Trial
31%
Diseases
30%
Placebo
28%
Rat Model
28%
Mangiferin
27%
Malignant Neoplasm
26%
Moringa oleifera
26%
Pharmacokinetics
25%
Iron
25%
Tumor Necrosis Factor
24%
Cardiotoxicity
24%
Clinical Trial
23%
Biological Marker
23%
Cross-Sectional Study
22%
Caspase 3
21%
Infection
20%
Malonaldehyde
19%
Daunorubicin
19%
Side Effect
18%
Iron Poisoning
18%
Nephrotoxicity
17%
Receptor
17%
Cyclorphan
17%
Cytokine
17%
Primaquine
17%
Adverse Event
17%
Adverse Drug Reaction
16%
Platelet-Rich Fibrin
16%
Insulin Resistance
16%
Normal Human
15%
Ovary Cancer
15%
Interleukin 6
15%
Hyaluronic Acid
14%
Clopidogrel
14%
Fibrosis
14%
Mouse Model
14%
Congestive Heart Failure
14%
Liver Fibrosis
14%
Creatinine
13%
Effusion
13%
Antiinflammatory Activity
13%
Neuroprotective Agent
13%
Rifampicin
13%
Myocardial Disease
12%
Non Insulin Dependent Diabetes Mellitus
12%
Cytotoxicity
12%
Sorafenib
12%
Metabolic Syndrome X
12%
Diabetic Nephropathy
12%
Wound
12%
Angiotensin II
12%
Tamoxifen
12%
Angiotensin
11%
Triple Negative Breast Cancer
11%
Azoxymethane
11%
Chitosan Nanoparticle
11%
Olmesartan
11%
P-Glycoprotein
11%
Liver Injury
11%
Combination Therapy
11%
Transcription Factor Nrf2
11%
Anti-Inflammatory Drug
11%
Experimental Autoimmune Myocarditis
11%
Bioavailability
11%
Observational Study
11%
Diabetic Cardiomyopathy
11%
Cardiovascular Disease
11%
Heart Muscle Fibrosis
11%
Prevalence
11%
Andrographolide
11%
Acetylsalicylic Acid
11%
Cell Viability
11%
Quercetin
10%
Fructose
10%
Telmisartan
10%
Nanoparticle
10%
Renin
10%
Antioxidant Capacity
10%
Midazolam
10%
Plasmodium Vivax Malaria
10%
Hypoxia
10%
Imatinib
9%
HIV
9%
Chloroquine
9%
Congestive Cardiomyopathy
9%
Chemotherapy
9%
Colorectal Carcinoma
9%
Radiosensitizing Agent
9%
Chlorpyrifos
9%